Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 Study of Adefovir Dipivoxil (Hepsera) in Children and Adolescents with Chronic Hepatitis B
2004-001346-33Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Sep 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chronic Hepatitis B (CHB) comparing Hepsera with Placebo (2 arms). Primary endpoints: Primary virologic and biochemical response at week 48 and Safety over 48 weeks. Started Sep 2004; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2004-001346-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001346-33.